UNIVERSAL HEALTH SERVICES INC Insider Trading Activity

Universal Health Services (UHS) director Elliot J. Sussman, M.D., reported insider transactions.

Accepted by SEC EDGAR 10/30/2025 - 04:23 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Universal Health Services (UHS) director Elliot J. Sussman, M.D., reported insider transactions. On 10/29/2025, he exercised 2,500 options at $138.80 per share (code M), satisfied taxes through the withholding of 1,535 shares at $226.15 (code F), and sold 965 shares at a weighted average price of $225.6981 (code S).

Following these transactions, his directly held Class B common shares were 6,113. The sale price reflects multiple trades between $225.38 and $225.80 as disclosed.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider SUSSMAN ELLIOT J MD MBA

Role Director

Sold 965 shs ($218K)

Approx. gross sale proceeds $218K

Approx. exercise cost $347K

Share of Position Sold 13.6%

Type	Security	Shares	Price	Value
Exercise	Option To Purchase Class B Common Stock	2,500	$0.00	$0.00
Exercise	Class B Common Stock	2,500	$138.80	$347K
Exercise Price or Tax Liability	Class B Common Stock	1,535	$226.15	$347K
Sale	Class B Common Stock	965	$225.6981	$218K

Holdings After Transaction: Option To Purchase Class B Common Stock — 2,500 contracts (Direct); Class B Common Stock — 6,113 shares (Direct)

Holdings Before and After: Option To Purchase Class B Common Stock, 5,000 to 2,500 contracts (Direct); Class B Common Stock, 6,113 to 6,113 shares (Direct)

Footnotes (2)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.38 to $225.80, inclusive. The reporting person undertakes to provide Universal Health Services, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 1.
2. F2. Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SUSSMAN ELLIOT J MD MBA

(Last) (First) (Middle)

THE VILLAGES HEALTH

3619 KIESSEL ROAD

(Street)

THE VILLAGES FL 32163

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL HEALTH SERVICES INC [ UHS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class B Common Stock	10/29/2025		M		2,500	A	$138.8	8,613	D
Class B Common Stock	10/29/2025		F		1,535	D	$226.15	7,078	D
Class B Common Stock	10/29/2025		S(1)		965	D	$225.6981	6,113	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option To Purchase Class B Common Stock	$138.8	10/29/2025		M			2,500	(2)	03/16/2026	Class B Common Stock	2,500	$0	2,500	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.38 to $225.80, inclusive. The reporting person undertakes to provide Universal Health Services, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 1.

2. Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

	/s/ Elliot J. Sussman, M.D.	10/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.